Published in Blood Weekly, July 10th, 2003
"Allogeneic peripheral blood stem cell transplantation (PBSCT) has emerged as an alternative to bone marrow transplantation," researchers in France explained. However, "PBSCT can be associated with a higher incidence of chronic graft-versus-host disease (cGVHD)."
M. Mohty and colleagues at the Paoli-Calmettes Institute in Marseille "investigated whether there was a correlation between the composition of PBSC grafts (CD34+ and CD3+ cells) and hematological recovery, GVHD, relapse, and relapse-free survival (RFS) after myeloablative HILA-identical sibling...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.